Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Protea Announces Release of New Gel Protein Recovery System

Published: Thursday, February 13, 2014
Last Updated: Thursday, February 13, 2014
Bookmark and Share
The Gel Protein Recovery GPR-850 System enables intact protein recovery from polyacrylamide gels for top-down proteomics applications.

Protea Biosciences Group, Inc. has announced the release of their advanced Gel Protein Recovery GPR-850 instrument. The GPR® System delivers efficient recovery of gel separated intact proteins through a multiplexed, automated, microfluidics chip-based process.

The GPR System (consisting of the GPR-850 instrument, GPRchips™, and GPR Buffers and Reagents) enables researchers to recover intact proteins and peptides for subsequent top-down proteomics experiments. This process facilitates effective protein identification, characterization and quantitation by mass spectrometry.

The effectiveness of the system is enhanced by the use of proprietary reagents (which utilize Protea’s Progenta™ Surfactants technology) together with the microfluidic-based GPRchip.

The GPR System combines these components to provide a high throughput recovery platform for researchers interested in studying intact proteins.

The GPR System features several kits specifically designed for specialized down-stream mass spec applications, including ESI-MS and LC-MALDI.

The new GPR-850 instrument features an updated user interface, improved mechanical and industrial design, and comes in six different colors to match the personalities of researchers, laboratories, or institutions.

Researchers interested in the GPR System have the option to enroll in the “30 Days of Experience” program. The program enables researchers to use a GPR-850 instrument in their lab for 30 days before purchasing.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Protea Announces Agreement to Acquire vivoPharm
Combined Company to develop and market new services for pharmaceutical R&D.
Thursday, April 09, 2015
Protea to Acquire vivoPharm
Combined company to develop and market new services for pharmaceutical R&D.
Wednesday, April 08, 2015
National Institute For Occupational Safety And Health Partners With Protea
NIOSH utilizes mass spectrometry imaging tools for workplace toxin inhalation studies.
Friday, March 20, 2015
Protea, MSK, Dana-Farber Enter Collaborative Research Agreement
Protea's LAESI technology to be used to profile cancer cells to improve diagnosis and treatment selection
Wednesday, April 30, 2014
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos